These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23807081)

  • 1. Portrait: coincidences, convergences and opportunities.
    Granoff DM
    Hum Vaccin Immunother; 2013 May; 9(5):945-9. PubMed ID: 23807081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jonas Salk (1914-1995): Pioneering the Fight Against Polio and Beyond.
    Sahu H; Choudhari SG; Gaidhane A; Chakole S
    Cureus; 2024 Sep; 16(9):e69681. PubMed ID: 39429327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polio and Nobel prizes: looking back 50 years.
    Norrby E; Prusiner SB
    Ann Neurol; 2007 May; 61(5):385-95. PubMed ID: 17469121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond Profit: The Ethical Compass of Banting and Salk in Medical Innovation.
    Pathan SR; Sharma KB
    Cureus; 2024 Apr; 16(4):e57698. PubMed ID: 38711690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of meningococcal vaccines and their serological correlates of protection.
    Vipond C; Care R; Feavers IM
    Vaccine; 2012 May; 30 Suppl 2():B10-7. PubMed ID: 22607894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a vaccine against serogroup B has been the main scientific challenge. Preface.
    Rappuoli R; Pizza M; Black S; Moxon ER
    Vaccine; 2012 May; 30 Suppl 2():B1-2. PubMed ID: 22607893
    [No Abstract]   [Full Text] [Related]  

  • 7. Cuban Meningococcal Vaccine VA-MENGOC-BC:30 Years of Use and Future Potential.
    Sierra-González VG
    MEDICC Rev; 2019 Oct; 21(4):19-27. PubMed ID: 32335565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nobel Chronicles. 1954: John Franklin Enders (1897-1985); Thomas Huckle Weller (b 1915); and Frederick Chapman Robbins (b 1916).
    Raju TN
    Lancet; 1999 May; 353(9165):1716. PubMed ID: 10335827
    [No Abstract]   [Full Text] [Related]  

  • 9. Classics in infectious diseases. The cultivation of the poliomyelitis viruses in tissue culture by John F. Enders, Frederick C. Robbins, and Thomas H. Weller.
    Enders JF; Robbins FC; Weller TH
    Rev Infect Dis; 1980; 2(3):493-504. PubMed ID: 6251529
    [No Abstract]   [Full Text] [Related]  

  • 10. Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.
    Dull PM; McIntosh ED
    Vaccine; 2012 May; 30 Suppl 2():B18-25. PubMed ID: 22607895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
    Pace D; Pollard AJ
    Arch Dis Child; 2007 Oct; 92(10):909-15. PubMed ID: 17895339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on Haemophilus influenzae serotype b and meningococcal vaccines.
    Rosenstein NE; Perkins BA
    Pediatr Clin North Am; 2000 Apr; 47(2):337-52, vi. PubMed ID: 10761507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The history of polio in Sweden - from infantile paralysis to polio vaccine].
    Axelsson P
    Sven Med Tidskr; 2004; 8(1):57-66. PubMed ID: 16025605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease among United States military service members in relation to routine uses of vaccines with different serogroup-specific components, 1964-1998.
    Brundage JF; Ryan MA; Feighner BH; Erdtmann FJ
    Clin Infect Dis; 2002 Dec; 35(11):1376-81. PubMed ID: 12439801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.
    Findlow H; Borrow R
    Adv Ther; 2013 May; 30(5):431-58. PubMed ID: 23712402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicine and the media: polio still paralyses (Albert Sabin, Jonas Salk).
    Dixon B
    Br J Hosp Med; 1977 Dec; 18(6):595. PubMed ID: 342023
    [No Abstract]   [Full Text] [Related]  

  • 17. Opportunities for control of meningococcal disease in the United States.
    Raghunathan PL; Bernhardt SA; Rosenstein NE
    Annu Rev Med; 2004; 55():333-53. PubMed ID: 14746525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and epidemiological implications of meningococcal disease.
    Meredith ; Galwankar S
    J Assoc Physicians India; 2005 Jul; 53():628-33. PubMed ID: 16190134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal conjugate vaccine in adolescents and children.
    Pichichero ME
    Clin Pediatr (Phila); 2005; 44(6):479-89. PubMed ID: 16015394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.